Tizanidine 60760-0505
Product NDC
60760-0505- Manufacturer
- St. Mary's Medical Park Pharmacy
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 21, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA076286
Need to source Tizanidine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tizanidine Hydrochloride | 4 mg/1 |
Drug Class
Adrenergic alpha2-Agonists [MoA]Central alpha-2 Adrenergic Agonist [EPC]
Packaging Options(5)
4 TABLET in 1 BOTTLE, PLASTIC (60760-505-04)
15 TABLET in 1 BOTTLE, PLASTIC (60760-505-15)
30 TABLET in 1 BOTTLE, PLASTIC (60760-505-30)
60 TABLET in 1 BOTTLE, PLASTIC (60760-505-60)
90 TABLET in 1 BOTTLE, PLASTIC (60760-505-90)